Beta Bionics, Inc. · NASDAQ:BBNX
Sands Capital Life Sciences Pulse Fund II. L.P. reported a 8.20% stake in Beta Bionics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 13, 2025
Sands Capital Life Sciences Pulse Fund II. L.P. reported a 8.20% stake in Beta Bionics, Inc., 3,570,113 shares, as a passive investor on Jun 30, 2025. Filed Aug 13, 2025 (Schedule 13G/A).
- Stake
- 8.20%
- Shares
- 3,570,113
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sands Capital Life Sciences Pulse Fund II. L.P. | 8.20% | 3,570,113 |
| Sands Capital Alternatives, LLC | 8.20% | 3,570,113 |
| SANDS FRANK M. | 8.20% | 3,570,113 |
Source
Related
- Beta Bionics, Inc.
- Sands Capital Life Sciences Pulse Fund II, L.P.
- Beta Bionics, Inc. shareholders
- Schedule 13G · Sands Capital Life Sciences Pulse Fund II, L.P. · Apr 9, 2025
- Form 4 · Hopman Mark · Oct 16, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Oct 7, 2026
- Form 4 · Hopman Mark · Oct 5, 2026
- Form 4 · Jones Christy · Sep 23, 2026
- Form 4/A · Hopman Mark · Sep 18, 2026